Abstract
Introduction
We report our first clinical experience with a CE-marked flexible monorail balloon-expandable stent for treatment of high-grade intracranial stenoses.
Methods
Between April 2006 and November 2007 21 patients with symptomatic intracranial stenoses (>70%) were treated with the PHAROS stent. In seven patients, the procedure was performed during acute stroke intervention. Procedural success, clinical complication rates and mid-term follow-up data were prospectively recorded.
Results
During a median follow-up period of 7.3 months one additional patient died of an unknown cause 3 months after the intervention. A patient with a significant residual stenosis presented with a new stroke after further progression of the residual stenosis. None of the successfully treated patients experienced ipsilateral stroke.
Conclusion
Recanalization of intracranial stenoses with the balloon-expandable Pharos stent is technically feasible. The periprocedural complication rate and mid-term follow-up results were in the range of previously reported case series. This pilot study was limited by the small sample size and severe morbidity of the included patients. Final evaluation of the efficacy of Pharos stent treatment demands further investigation.
Similar content being viewed by others
References
Meyers PM, Schumacher HC, Tanji K, Higashida RT, Caplan LR (2007) Use of stents to treat intracranial cerebrovascular disease. Annu Rev Med 58:107–122
Higashida RT, Meyers PM, Connors JJ 3rd, Sacks D, Strother CM, Barr JD, Wojak JC, Duckwiler GR; American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Society of Neuroradiology (2005) Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. AJNR Am J Neuroradiol 26:2323–2327
Berkefeld J, Hammann GF, du Mesnil R, Kurre W, Steinmetz H, Zanella FE, Sitzer M (2006) Endovascular treatment for intracranial stenoses – a common statement by neurologists and neuroradiologists. Nervenarzt 77(12):1444–1455
SSYLVIA Study Investigators (2004) Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35:1388–1392
du Mesnil de Rochemont, Turowski B, Buchkremer M, Sitzer M, Zanella FE, Berkefeld J (2004) Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents – initial experience. Radiology 231:45–49
Weber W, Mayer TE, Henkes H, Kis B, Hamann GF, Schulte-Altedornenburg G, Brückmann H, Kuehne D (2005) Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. Eur J Radiol 55:231–236
Yu W, Smith WS, Singh V, Ko NU, Cullen SP, Dowd CF, Halbach VV, Higashida RT (2005) Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 64:1055–1057
Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA (2005) Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol 26(4):869–874
Abou-Chebl A, Krieger DW, Gajzer CT, Yadav JS (2006) Intracranial angioplasty and stenting in the awake patient. J Neuroimaging 16(3):216–223
Lylyk P, Vila JF, Miranda C, Ferrario A, Musacchio A, Rüfenacht D, Cohen JE (2005) Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 27 [Suppl 1]:S84–S88
Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT (2006) Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 66:1868–1872
Jiang WJ, Du B, Leung TW, Xu XT, Jin M, Dong KH (2007) Symptomatic intracranial stenoses: cerebrovascular complications from elective stent placement. Radiology 243(1):188–197
Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N (2007) Comparison of elective stenting of severe versus moderate intracranial atherosclerotic stenosis. Neurology 68:420–426
Fiorella D, Chow MM, Anderson M, Woo H, Rassmussen PA, Masaryk TJ (2007) A 7-year experience with balloon mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 61:236–243
Levy EI, Turk A, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rassmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ (2007) Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 61:644–651
Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chatuverdi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators (2006) Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113:555–563
Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F (2006) Prospective study of symptomatic atherothrombotic intracranial stenoses – the GESICA study. Neurology 66:1187–1191
Thijs VN, Alberts GW (2000) Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 55(4):490–497
Henkes H, Miloslavki E, Lowens S, Reinatz J, Liebig T, Kühne D (2005) Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 47:222–228
Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP (2007) A novel, self expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses. Stroke 38:1531–1537
Freitas JM, Zenteno M, Aburto-Murrieta Y, Koppe G, Abath C, Nunes JA, Raupp E, Hidalgo R, Pieruccetti MA (2007) Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol 68:378–386
Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI (2000) A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21(4):643–646
US Food and Drug Administration (2008) Premarket Approval (PMA) Database, No. P030037. Center for Devices and Radiological Health. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/PMA.cfm?ID=2969
Prabhakaran S, Wells KR, Lee VH, Flaherty CA, Lopes DK (2008) Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR Am J Neuroradiol 29:281–285
Cruz-Flores S, Diamond AL (2006) Angioplasty for intracranial artery stenosis. Cochrane Database of Systematic Reviews, issue 3, article no.: CD004133. DOI 10.1002/14651858.CD004133.pub2
Levy EI, Metha R, Gupta R, Hanel RA, Chamzuk AJ, Fiorella D, Woo HH, Albuquerque FC, Jovin TG, Horowitz MB, Hopkins LN (2007) Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 28(5):816–822
Conflict of interest statement
Professor Berkefeld is principal investigator of the German Pharos registry and consultant of Micrus endovascular in this regard.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kurre, W., Berkefeld, J., Sitzer, M. et al. Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology 50, 701–708 (2008). https://doi.org/10.1007/s00234-008-0394-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-008-0394-6